DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado de Ciencias de la Salud
DAVID
LORA PABLOS
Profesor asociado
Publikationen, an denen er mitarbeitet DAVID LORA PABLOS (6)
2021
-
Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.
OncoImmunology, Vol. 10, Núm. 1
-
Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy
Clinical Genitourinary Cancer, Vol. 19, Núm. 2, pp. 95-102
2020
-
Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials
Clinical and Translational Oncology, Vol. 22, Núm. 11, pp. 2126-2129
-
The value of pd-l1 expression as predictive biomarker in metastatic renal cell carcinoma patients: A meta-analysis of randomized clinical trials
Cancers, Vol. 12, Núm. 7, pp. 1-16
2019
-
Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: A meta-analysis of randomized clinical trials
Oncotarget, Vol. 10, Núm. 35, pp. 3294-3301
2018
-
Analysis of response rate with ANTI-PD1/PDL-1 monoclonal antibodies in advanced solid tumors: A meta-analysis of randomized clinical trials
Oncotarget, Vol. 9, Núm. 9, pp. 8706-8715